Cite
HARVARD Citation
Chevallier, P. et al. (2021). A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients. Human vaccines & immunotherapeutics. 17 (10), pp. 3511-3514. [Online].